MedPath

Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes

Not Applicable
Completed
Conditions
Paroxysmal Supraventricular Tachycardia
Interventions
Device: Microfidelity (MIFI) catheter
Device: Conventional ablation catheter
Registration Number
NCT04215640
Lead Sponsor
Yong Seog Oh
Brief Summary

Paroxysmal supraventricular tachycardia is treated with radiofrequency ablation recently. This procedure is performed by ablating slow pathway or accessory pathway using radiofrequency ablation catheter. Recently developed mirofidelity (MIFI) catheter has mini-electrodes that can record local eletrogram with higher resolution. We aimed to investigate the efficacy of MIFI catheter in the ablation of paroxysmal supraventricular tachycardia compared to conventional radiofrequency ablation catheter. Enrolled patients undergo conventional electrophysiologic study. Patients with sustained supraventricular tachycardia during the study are randomized to either study group or control group. Radiofrequency ablation is performed using MIFI catheter in the study group, and conventional catheter (Blazer II) in the control group. The study endpoints are recorded immediately after ablation and there is no additional follow up or management after procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
136
Inclusion Criteria
  • Patients who are scheduled to undergo radiofrequency ablation for paroxysmal supraventricular tachycardia or WPW syndrome with atrial fibrillation
  • Give written informed consent for the study
Exclusion Criteria
  • Unable to induce supraventricular tachycardia during electrophysiologic study.
  • Cognitive impairment to understand study procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MIFI groupMicrofidelity (MIFI) catheterPatients in the MIFI group receive standard radiofrequency ablation procedure for the supraventricular tachycardia using microfidelity (MIFI) catheter.
ControlConventional ablation catheterPatients in the control group receive standard radiofrequency ablation procedure for the supraventricular tachycardia using conventional ablation catheter (Blazer II).
Primary Outcome Measures
NameTimeMethod
RF time (seconds) to successful ablationAt the end of radiofrequency ablation procedure

For AVNRT, the time (seconds) from the beginning of radiofrequency ablation to the emergence of junctional rhythm For AVRT, the time (seconds) from the beginning of radiofrequency ablation to the accessory pathway block

RF application numberAt the end of radiofrequency ablation procedure

Number of radiofrequency ablation attempt to successful ablation

Secondary Outcome Measures
NameTimeMethod
Total ablation time (seconds)At the end of radiofrequency ablation procedure

Total time of radiofrequency energy delivery

Presence of either acute reconnection or reinductionAt the end of radiofrequency ablation procedure

Acute accessory pathway reconnection or supraventricular tachycardia reinduction after ablation

Trial Locations

Locations (1)

Seoul St Mary's Hospital

🇰🇷

Seoul, Seo Ch-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath